CELLEBRITE DI LTD (CLBT) Stock Fundamental Analysis
USA - NASDAQ:CLBT - IL0011794802 - Common Stock
17.26 USD
-0.17 (-0.98%)
17.1316 USD
-0.13 (-0.74%)
Overall CLBT gets a fundamental rating of 5 out of 10. We evaluated CLBT against 280 industry peers in the Software industry. CLBT has an excellent financial health rating, but there are some minor concerns on its profitability. CLBT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CLBT had positive earnings in the past year.
In the past year CLBT had a positive cash flow from operations.
In multiple years CLBT reported negative net income over the last 5 years.
In the past 5 years CLBT always reported a positive cash flow from operatings.
1.2 Ratios
CLBT has a Return On Assets of -19.17%. This is in the lower half of the industry: CLBT underperforms 71.79% of its industry peers.
CLBT's Return On Equity of -36.96% is on the low side compared to the rest of the industry. CLBT is outperformed by 64.64% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.23%, CLBT belongs to the top of the industry, outperforming 86.07% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CLBT is below the industry average of 11.85%.
The 3 year average ROIC (7.06%) for CLBT is below the current ROIC(10.23%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.17% | ||
| ROE | -36.96% | ||
| ROIC | 10.23% |
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
1.3 Margins
CLBT's Operating Margin of 14.16% is fine compared to the rest of the industry. CLBT outperforms 80.00% of its industry peers.
In the last couple of years the Operating Margin of CLBT has grown nicely.
Looking at the Gross Margin, with a value of 84.38%, CLBT belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
CLBT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.16% | ||
| PM (TTM) | N/A | ||
| GM | 84.38% |
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
2. Health
2.1 Basic Checks
CLBT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CLBT has been increased compared to 1 year ago.
CLBT has more shares outstanding than it did 5 years ago.
There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
CLBT has an Altman-Z score of 7.72. This indicates that CLBT is financially healthy and has little risk of bankruptcy at the moment.
CLBT has a Altman-Z score of 7.72. This is in the better half of the industry: CLBT outperforms 78.93% of its industry peers.
There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 7.72 |
ROIC/WACC1.14
WACC8.95%
2.3 Liquidity
CLBT has a Current Ratio of 1.96. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
CLBT has a Current ratio of 1.96. This is in the better half of the industry: CLBT outperforms 60.71% of its industry peers.
CLBT has a Quick Ratio of 1.92. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
CLBT has a better Quick ratio (1.92) than 60.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.92 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.75% over the past year.
The Revenue has grown by 20.48% in the past year. This is a very strong growth!
The Revenue has been growing by 18.47% on average over the past years. This is quite good.
EPS 1Y (TTM)16.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)20.48%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%18.35%
3.2 Future
CLBT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.94% yearly.
The Revenue is expected to grow by 15.18% on average over the next years. This is quite good.
EPS Next Y17.86%
EPS Next 2Y12.72%
EPS Next 3Y12.96%
EPS Next 5Y12.94%
Revenue Next Year17.76%
Revenue Next 2Y17.22%
Revenue Next 3Y17.04%
Revenue Next 5Y15.18%
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 37.52 indicates a quite expensive valuation of CLBT.
Compared to the rest of the industry, the Price/Earnings ratio of CLBT indicates a somewhat cheap valuation: CLBT is cheaper than 61.43% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CLBT to the average of the S&P500 Index (27.20), we can say CLBT is valued slightly more expensively.
Based on the Price/Forward Earnings ratio of 32.35, the valuation of CLBT can be described as expensive.
Based on the Price/Forward Earnings ratio, CLBT is valued a bit cheaper than 61.07% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.71. CLBT is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.52 | ||
| Fwd PE | 32.35 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLBT indicates a somewhat cheap valuation: CLBT is cheaper than 64.29% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CLBT is valued a bit cheaper than the industry average as 74.29% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.32 | ||
| EV/EBITDA | 47.69 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLBT does not grow enough to justify the current Price/Earnings ratio.
CLBT's earnings are expected to grow with 12.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.1
PEG (5Y)N/A
EPS Next 2Y12.72%
EPS Next 3Y12.96%
5. Dividend
5.1 Amount
No dividends for CLBT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
17.26
-0.17 (-0.98%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners42.46%
Inst Owner Change5.47%
Ins Owners2.71%
Ins Owner ChangeN/A
Market Cap4.22B
Analysts84.29
Price Target23.46 (35.92%)
Short Float %4.75%
Short Ratio2.9
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.37%
Min EPS beat(2)12.81%
Max EPS beat(2)15.93%
EPS beat(4)4
Avg EPS beat(4)21.79%
Min EPS beat(4)0.93%
Max EPS beat(4)57.51%
EPS beat(8)8
Avg EPS beat(8)51.82%
EPS beat(12)11
Avg EPS beat(12)53.22%
EPS beat(16)13
Avg EPS beat(16)50.32%
Revenue beat(2)0
Avg Revenue beat(2)-2.3%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)-1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)2.78%
Revenue beat(8)5
Avg Revenue beat(8)0.93%
Revenue beat(12)7
Avg Revenue beat(12)0.54%
Revenue beat(16)9
Avg Revenue beat(16)0.41%
PT rev (1m)-8%
PT rev (3m)-8%
EPS NQ rev (1m)1.51%
EPS NQ rev (3m)5.16%
EPS NY rev (1m)5.76%
EPS NY rev (3m)5.76%
Revenue NQ rev (1m)-1.58%
Revenue NQ rev (3m)-3.61%
Revenue NY rev (1m)-0.98%
Revenue NY rev (3m)-0.98%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.52 | ||
| Fwd PE | 32.35 | ||
| P/S | 9.66 | ||
| P/FCF | 28.32 | ||
| P/OCF | 26.2 | ||
| P/B | 10.33 | ||
| P/tB | 11.42 | ||
| EV/EBITDA | 47.69 |
EPS(TTM)0.46
EY2.67%
EPS(NY)0.53
Fwd EY3.09%
FCF(TTM)0.61
FCFY3.53%
OCF(TTM)0.66
OCFY3.82%
SpS1.79
BVpS1.67
TBVpS1.51
PEG (NY)2.1
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.17% | ||
| ROE | -36.96% | ||
| ROCE | 12.96% | ||
| ROIC | 10.23% | ||
| ROICexc | 926.92% | ||
| ROICexgc | N/A | ||
| OM | 14.16% | ||
| PM (TTM) | N/A | ||
| GM | 84.38% | ||
| FCFM | 34.12% |
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.94%
ROCE(5y)9.6%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
F-Score5
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 114.28% | ||
| Cap/Sales | 2.77% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 222.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 7.72 |
F-Score5
WACC8.95%
ROIC/WACC1.14
Cap/Depr(3y)92.67%
Cap/Depr(5y)99.76%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y17.86%
EPS Next 2Y12.72%
EPS Next 3Y12.96%
EPS Next 5Y12.94%
Revenue 1Y (TTM)20.48%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%18.35%
Revenue Next Year17.76%
Revenue Next 2Y17.22%
Revenue Next 3Y17.04%
Revenue Next 5Y15.18%
EBIT growth 1Y23.19%
EBIT growth 3Y30.51%
EBIT growth 5YN/A
EBIT Next Year30.19%
EBIT Next 3Y22.99%
EBIT Next 5Y19.13%
FCF growth 1Y160.75%
FCF growth 3Y63.25%
FCF growth 5Y65.07%
OCF growth 1Y150.74%
OCF growth 3Y54.2%
OCF growth 5Y52.3%